Our goal is that all participants in the market have access to consistent, relevant and sufficient information on the factors affecting the value of the company’s share or other financial instrument as quickly as possible and at the same time.

Admicom’s website https://investors.admicom.fi and our company releases are the most important publication channels for information on our operations and finances. All stakeholders have equal access to the information published on the website.

Join mailing list

Investor calendar

Key dates for financial reports, investor events and other important occasions regarding Admicom Oyj are presented here.

Upcoming releases and events Dat
Annual report of 2024  January 23, 2025 at araound 8 a.m. (EET)
AGM 2025 appr. March 19, 2025
Business review Q1, 2025 April 9, 2025 at around 8 a.m. (EEST)
Half-year financial review H1, 2025 July 8, 2025 at around 8 a:m (EEST)
Business review Q3, 2025 October 9, 2025 at around 8 a.m. (EEST)
Previous investor events Date
Q3 results, 2024 -webcast, watch video (in English)
October 9, 2024
Q2 results, 2024 -webcast, watch video (in English)
July 9, 2024
2023 results webcast, watch video (in English) January 19, 2024
Capital Markets Day 2023, watch video (in English January 30, 2023

 

 

IR-contacts

The CEO and CFO of Admicom are responsible for the investor relations.

Admicom practices so-called silent periods 30 days prior to the date of issuing interim reports or full-year results release. During this time, representatives of the company will not comment on the company’s financial performance or on future outlooks. Dates for financial reports are published in the investor calendar.

Approved advisor

Oaklins Finland Oy
Pohjoisesplanadi 27 C (5th floor)
00100 Helsinki
Finland

 

Analyses

Inderes Oyj, an analysis company focused on stock research, monitors Admicom Corporation and prepares investment analyses for Admicom.

Analyses are also provided by:

Admicom is not responsible for the content or estimates presented in external investment analyses.